UPDATE 3-AbbVie delivers on strong growth of Humira arthritis drug

April 26 (Reuters) - AbbVie Inc's quarterly profit rose 10 percent on surging sales of its Humira treatment for rheumatoid arthritis, and the company said it plans to launch several potentially lucrative new treatments for hepatitis C by early 2015.